JP2024539273A5 - - Google Patents
Info
- Publication number
- JP2024539273A5 JP2024539273A5 JP2024524598A JP2024524598A JP2024539273A5 JP 2024539273 A5 JP2024539273 A5 JP 2024539273A5 JP 2024524598 A JP2024524598 A JP 2024524598A JP 2024524598 A JP2024524598 A JP 2024524598A JP 2024539273 A5 JP2024539273 A5 JP 2024539273A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271368P | 2021-10-25 | 2021-10-25 | |
| US63/271,368 | 2021-10-25 | ||
| US202163279527P | 2021-11-15 | 2021-11-15 | |
| US63/279,527 | 2021-11-15 | ||
| PCT/US2022/078597 WO2023076863A2 (en) | 2021-10-25 | 2022-10-24 | Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024539273A JP2024539273A (ja) | 2024-10-28 |
| JP2024539273A5 true JP2024539273A5 (https=) | 2025-10-31 |
| JPWO2023076863A5 JPWO2023076863A5 (https=) | 2025-10-31 |
Family
ID=86158936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524598A Pending JP2024539273A (ja) | 2021-10-25 | 2022-10-24 | Ｍａｇｅ－ａ４抗原を標的とするペプチドおよび操作されたｔ細胞受容体ならびに使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4422651A4 (https=) |
| JP (1) | JP2024539273A (https=) |
| CA (1) | CA3236237A1 (https=) |
| WO (1) | WO2023076863A2 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMT202100564T1 (it) * | 2016-04-08 | 2022-01-10 | Adaptimmune Ltd | Recettori di cellule t |
| AU2018318303A1 (en) * | 2017-08-18 | 2020-04-09 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| US20210061914A1 (en) * | 2017-12-28 | 2021-03-04 | Gritstone Oncology, Inc. | Antigen-Binding Proteins Targeting Shared Antigens |
| BR112021025548A2 (pt) * | 2019-06-18 | 2022-05-17 | Regeneron Pharma | Receptores de células t mage-a4 e métodos de uso dos mesmos |
| WO2021236548A1 (en) * | 2020-05-18 | 2021-11-25 | Board Of Regents, The University Of Texas System | Engineered t cell receptors and methods of use |
-
2022
- 2022-10-24 CA CA3236237A patent/CA3236237A1/en active Pending
- 2022-10-24 WO PCT/US2022/078597 patent/WO2023076863A2/en not_active Ceased
- 2022-10-24 EP EP22888415.1A patent/EP4422651A4/en not_active Withdrawn
- 2022-10-24 JP JP2024524598A patent/JP2024539273A/ja active Pending